GBC Blog

NEW YORK, Aug 8 (Reuters) – Recursion Pharmaceuticals (RXRX.O), opens new tab, a biotech firm which uses artificial intelligence to discover new drug candidates, has agreed to buy smaller rival Exscientia (EXAI.O), opens new tab for $688 million in an all-stock deal, according to a statement seen by Reuters. The deal, which is expected to be announced as…

Researchers at the Fred Hutchinson Cancer Center have unveiled a new type of blood test used to detect colorectal cancer, with high hopes not only in its ability to reduce barriers to testing for this particular disease, but also potentially pave the way for many other types of cancer screenings. The study, published last week in the…

SEATTLE — March 20, 2024 — Researchers at Fred Hutchinson Cancer Center have found that a specific subtype of a microbe commonly found in the mouth is able to travel to the gut and grow within colorectal cancer tumors. This microbe is also a culprit for driving cancer progression and leads to poorer patient outcomes after cancer…

Read the KLAS Research ‘US Digital Pathology 2023’ Performance Insights report. Philips has helped more than 300 customers transition to a fully digital workflow, with many more using Philips IntelliSite Pathology solution as an open platform for primary diagnosis The first company to introduce an FDA-approved digital pathology slide scanner for primary diagnostic use in 2017, Philips is one…

A team of researchers have identified epigenomic drivers associated with cancer development and progression, constructing a pan-cancer epigenetic and transcriptomic atlas from the data. This atlas “provides a foundation for further investigation of epigenetic dynamics in cancer transitions,” the study team, led by researchers from Washington University in St. Louis, wrote in Nature. The researchers used…

https://nationalcancerplan.cancer.gov/ We know that our continued progress against cancer is the direct result of advances made possible by investment from federal, state, and local governments, along with private investment, and by the sustained efforts of researchers around the world and millions of people with cancer, their caregivers, and advocates. Building on these tremendous efforts and…

On March 7, 2023, Robert Snyder, PhD, Associate Director of Genomics at Precision for Medicine, delivered a presentation entitled, Biobank Partnering for Clinical Trial Assay / CDx Development and High-throughput IHC & NGS Screening, at the 30th International Molecular Med Tri-Con Conference & Expo. As an end-to-end provider of biospecimens, specialty labs, and regulatory consulting services, Precision for…

SAN FRANCISCO, Feb. 2, 2023 /PRNewswire/ — Qvin™, the biotechnology company that developed the first and only healthcare service that scientifically collects menstrual blood to test for HR-HPV and other critical healthcare information, announced FDA approval in Thailand for its Q-Pad technology. Thailand has a population of 30 million women ages 15 years and older who are at risk of developing cervical…

January 27, 2022 – The Specimen Acquisition Network (SAN) was founded in 2019 when Fred Hutch reached out to academic centers across the Pacific Northwest region, spanning from British Columbia to Portland – leveraging connections through the Cascadia Data Alliance – to increase access to and awareness of available resources, share ideas and foster partnerships,…

Published:November 11, 2021DOI:https://doi.org/10.1016/j.cell.2021.10.015 Highlights Summary There is increasing interest in the potential contribution of the gut microbiome to autism spectrum disorder (ASD). However, previous studies have been underpowered and have not been designed to address potential confounding factors in a comprehensive way. We performed a large autism stool metagenomics study (n = 247) based on participants…